Latest news with #FrankfurtStockExchange
Globe and Mail
a day ago
- Business
- Globe and Mail
Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance
HAMBURG, DE / ACCESS Newswire / July 21, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces that it has updated its revenue guidance for the fiscal year 2025. Guidance on R&D expenses and adjusted EBITDA remains unchanged. For the current fiscal year, the Company expects Group revenues in the range of €760-800m (previously: € 840 - 880 m; 2024: € 797.0 m); R&D expenditures are expected in a range of €40 - 50 m (unchanged; 2024: € 50.8 m); Adjusted EBITDA is expected to reach €30-50m (unchanged; 2024: € 22.6 m). The primary reasons for the refined guidance are a change in the revenue mix and significant cost savings in excess of initial targets set during the Priority Reset. Technology licensing - a key pillar of Evotec's strategic repositioning - is expected to make a stronger contribution. At the same time, the Shared R&D base business is expected to continue to operate in a challenging market environment in the second half of 2025. Group revenues were below expectations in H1 2025, while adjusted EBITDA was broadly in line with expectations. Actions are underway to transform the business towards sustainable profitable growth. - End of the ad hoc release - View the original press release on ACCESS Newswire
Reuters
23-06-2025
- Business
- Reuters
Germany's Brainlab sets IPO price range at 80-100 euros per share
BERLIN, June 23 (Reuters) - German medical technology firm Brainlab said on Monday it had set the price range for its initial public offering (IPO) at 80 to 100 euros ($92.08-$115.10) per share. The Munich-based company, which said this month it is planning an IPO on the Frankfurt Stock Exchange in the coming weeks, said it is aiming for a market capitalisation of about 1.67 billion to 2.09 billion euros. ($1 = 0.8688 euros)
Yahoo
12-06-2025
- Business
- Yahoo
Enapter AG Completes Capital Increase
HAMBURG - June 12, 2025 (NEWMEDIAWIRE) - Enapter AG (ISIN: DE000A255G02) has completed its capital increase against cash contributions. Gross issue proceeds totaling around EUR 4.3 million were generated. Once again, strategic investors also participated. According to the company's current planning, financing is thus secured until the end of 2025. A total of 1,480,000 new shares will be issued, meaning that the share capital will amount to EUR 30,552,934 after entry in the commercial register. The new shares were placed at EUR 2.90 each. The net proceeds from this capital measure will be used for the general financing of current business activities. The listing of the new shares under the same ISIN as the existing shares on the Frankfurt Stock Exchange and the Hanseatic Stock Exchange in Hamburg is planned for on or around June 25, 2025, subject to the timely entry of the capital increase in the commercial register. The new shares will carry dividend rights from 01.01.2024. The capital increase was accompanied by mwb fairtrade Wertpapierhandelsbank AG as subscription agent. About Enapter Enapter is market leader in the field of AEM electrolyzers - innovative devices that produce green hydrogen. The company's patented and proven anion exchange membrane (AEM) technology eliminates the need for expensive and rare raw materials such as iridium and enables maximum yield from fluctuating renewable energies such as solar and wind through a unique modular design, resulting in highly efficient production of green hydrogen. Thousands of Enapter AEM electrolyzers are already in use by more than 360 customers in more than 55 countries in the fields of energy storage, industrial applications, refueling, power-to-X and research. The Enapter Group is headquartered in Germany with a research and production site in Italy and a joint venture with the Wolong Group in China. Enapter AG (H2O) is listed on the regulated market of the Frankfurt and Hamburg stock exchanges, ISIN: information:Website: Press contact:Ralf Droz / Doron Kaufmannedicto GmbHPhone: +49 (0) 69 90 55 05-54E-Mail: enapter@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Time of India
12-06-2025
- Business
- Time of India
German medical tech firm Brainlab plans Frankfurt IPO in coming weeks
Berlin: German medical technology firm Brainlab is planning an initial public offering on the Frankfurt Stock Exchange in the coming weeks, the company said on Thursday. The Munich-based company said it will list on the regulated market and aims to raise up to 200 million euros ($230 million) through the issuance of new shares. The firm will use the capital increase to grow its business, with a focus on expanding into additional clinical applications, as well as strengthen its balance sheet. The current owners also plan to place additional secondary shares to ensure significant free float, said the company. Majority shareholder Stefan Vilsmeier , who founded the company 35 years ago and recently announced his retirement from the operational business, is set to continue to support the company as a long-term investor. The initial public offering is being organised by Berenberg, Deutsche Bank, Commerzbank, Jefferies, and UniCredit. Evercore is also advising the company, which has around 2,000 employees. Brainlab's main products include software systems that are used as navigational tools by surgeons, for example during brain and hip surgery, and for spinal implants and fractures.
Yahoo
04-06-2025
- Business
- Yahoo
Highland Critical Minerals Corp. Announces Commencement of Trading on The Frankfurt Stock Exchange and RSU Issuance
Toronto, Ontario--(Newsfile Corp. - June 4, 2025) - Highland Critical Minerals Corp. (CSE: HLND) ("Highland" or the "Company") is pleased to announce that its class A common shares (the "Class A Common Shares") will commence trading on the Frankfurt Stock Exchange under the ticker symbol "U8X", effective June 4, 2025. Ted Yew, Director and Chief Executive Officer of Highland, commented: "We are delighted to begin trading on the Frankfurt Stock Exchange in an effort to further diversify our shareholder base. We look forward to providing our shareholders and the broader market with an update on our exploration results from the Church Property in the coming months. The Company also announces that it has adopted a restricted share unit ("RSU") plan and has granted an aggregate of 300,000 RSUs to certain directors, officers and consultants of the Company. Each RSU is exchangeable into one Class A Common Share upon vesting and will expire on June 4, 2027. The Canadian Securities Exchange has not in any way passed upon the merits of the matters referenced herein and has neither approved nor disapproved the contents of this news release. ABOUT HIGHLAND CRITICAL MINERALS CORP. Highland is a mineral exploration and development company. Its activities consist of acquiring and exploring, mining properties. It is anticipated that the Company will be mainly active in the field of mining exploration in Ontario, Canada and that a material part of the funds from subscriptions of the Special Warrants previously sold by the Company will be used in exploration work on the Church Property. For more information, please visit Forward-looking statement This news release includes certain statements that may be deemed "forward-looking statements." All statements in this new release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Forward-looking statements in this news release include, without limitation, statements related to the anticipated listing of the Common Shares on the CSE. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. The Company has applied several material assumptions in making such forward-looking statements, including without limitation: the timely receipt of all approvals relating to the CSE listing and assumptions about general economic and market conditions. Although management of the Company believes that the assumptions made and the expectations represented by such statements or information are reasonable, there can be no assurance that forward-looking statements or information herein will prove to be accurate. Forward-looking information by their nature are based on assumptions and involve known and unknown risks, uncertainties and other factors which may cause actual results, performance, or achievements expressed or implied by such forward-looking statements or information. Factors that could cause the actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions, risks that not all regulatory approvals (including CSE approval) are obtained, risks relating to the mining industry, and other factors discussed in the Company's long-form prospectus dated May 9, 2025. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change. For more information, please contact:Edward DisclaimerThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act"), or any securities laws and may not be offered or sold in the United States unless registered under the 1933 Act and any applicable securities laws of any state of the United States or an applicable exemption from such registration requirements is available. NOT FOR DISTRIBUITION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. To view the source version of this press release, please visit
